Michael J. Hochman
MD
Dr. Hochman treats patients with acute leukemia, myelodysplastic neoplasms and other myeloid malignancies.
Titles and Roles
- Assistant Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Hematologist
- Leukemia
- Myelodysplastic Syndromes
- Research Program
- Discovery and Developmental Therapeutics
Biography
Michael J. Hochman, MD, is assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A board certified hematologist, Dr. Hochman treats patients with acute leukemia, myelodysplastic neoplasms and other myeloid malignancies.
Dr. Hochman is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University. He& holds professional memberships with American Society of Hematology, American Society of Clinical Oncology and Society of Hematologic Oncology.
Education
Dr. Hochman received his Medical Degree from Duke University School of Medicine in Durham, North Carolina. He completed his residency at University of Washington Affiliated Hospitals in Seattle, Washington. He completed his fellowship in hematology at Johns Hopkins University School of Medicine in Baltimore, Maryland, where he served as Chief Fellow in his final year.
Research
Dr. Hochman's research focuses on developing novel therapeutic strategies for treatment of myeloid malignancies, including new drugs and drug combinations. He is also studying the use of new technologies to better predict treatment outcomes and assess measurable residual disease among clonal myeloid disorders.
Publications
Publications Publication Date
Awards
Dr. Hochman received the ASH Abstract Achievement Award for his work on ontogeny and genetics in acute myeloid leukemia, presented at the 2022 American Society of Hematology Annual Meeting.